Filing Flows › Novartis AG (NVS) › Gross margin
Novartis AG (NVS) gross margin by quarter
Novartis AG's gross margin was 78.6% in Q3 2026 (third quarter 2026), +0.6 pts from Q2 2026. Over the last 6 quarters it ranged from 76.8% (Q1 2026) to 81.9% (Q2 2025).
| Quarter | Gross margin | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | 78.6% | +0.6 pts | +0.9 pts |
| Q2 2026 | 78.0% | +1.3 pts | -3.9 pts |
| Q1 2026 | 76.8% | -0.1 pts | — |
| Q4 2025 | 76.9% | -0.9 pts | — |
| Q3 2025 | 77.8% | -4.1 pts | — |
| Q2 2025 | 81.9% | — | — |
Q3 2026 at a glance
Novartis AG, Q3 2026: revenue $14.5B (+4% year over year), operating margin 12.7%, net earnings $1.2B, operating cash flow $5.5B. The chart follows the revenue to costs, profit and cash.
Questions
What is Novartis AG's gross margin?
Novartis AG's gross margin was 78.6% in Q3 2026 (third quarter 2026), +0.6 pts from Q2 2026.
How has Novartis AG's gross margin changed?
Over the last 6 quarters it ranged from 76.8% (Q1 2026) to 81.9% (Q2 2025).